Dexcom Inc

NASDAQ: DXCM
$111.87
+$0.22 (+0.2%)
Real Time Data Delayed 15 Min.

DXCM Chart and Intraday Price

DXCM Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Address 6340 SEQUENCE DRIVE, SAN DIEGO, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 46,932.60M USD
Shares Outstanding 385,515,000
Dexcom Inc specializes in advanced medical devices for diabetes management, offering continuous glucose monitoring (CGM) systems. Their innovative products, including the Dexcom G6 and G7, help both individuals with diabetes and healthcare providers by providing real-time glucose data. Dexcom's technology also supports remote monitoring and integrates with digital health apps, aiming to make diabetes management more effective and less invasive. Based in San Diego, California, Dexcom is a leader in diabetes care technology, continuously working on new solutions like Dexcom Stelo for type 2 diabetes.

DXCM Articles

Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
U.S. equities are trading somewhat higher in Tuesday's premarket session as investors wait to hear what Federal Reserve chief Jerome Powell has to say to Congress.
Another cryptocurrency exchange is in hot water, and a little-known penny stock is making a big noise on a merger announcement.
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.
After a horrific year in the markets, Jefferies has made some big changes to its Franchise Picks list of top stocks. These eight outstanding additions to the list have plenty of upside potential and...
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, AES, Amazon.com, CommScope, Emerson Electric, Intel, Leslie’s, Microsoft, Paramount Global, Prologis, Rivian...
Monay's top analyst upgrades and downgrades included Block, Boeing, Chegg, Chesapeake Energy, DexCom, Duke Realty, JPMorgan Chase, Kraft Heinz, Merck, Netflix, Patterson-UTI Energy and TechnipFMC.
Here is a look at seven stocks that traded up and seven that traded lower in Wednesday's premarket session.
Friday's top analyst upgrades and downgrades included Agnico-Eagle Mines, Biogen, Exelon, Meta Platforms, New York Times, PulteGroup, Snap and Vertex Pharmaceutical.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Apple, Best Buy, Costco, Intel, Kansas City Southern, Nikola, Plug Power and Salesforce.com.
Here are two very timely additions to the BofA Securities Growth 10 portfolio and three others that offer growth investors some outstanding earnings growth potential. For those with a longer time...
BofA Securities feels these four top medtech companies are all poised for potential positive news and developments in the near future. These stocks could be good additions to growth portfolios...
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft, Pfizer and Wynn Resorts.
The S&P 500 index is up about 2% this year, after a spring collapse and remarkable rebound. Among the companies in the index, 10 are up more than 50%.
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate Technology, Sonos, Starbucks and T-Mobile.